High Drug Costs Are Awful. Reducing Them Can Be Worse.

While the current setup may be a foolish way of funding research, it would be much worse to have no funding at all.
But, unfortunately, the Trump administration has been considering an executive order that eases regulations on drug companies, even as it has proposed cuts in federal funding for drug research.
The net effect would increase our reliance on private companies to provide public research.
In the current situation, drug pricing and research funding are intertwined.
Advertisement Continue reading the main storyBecause industry pays for a large share of research, high drug prices do not just generate profits; they also become a funding source for important scientific work.

Read more on: http://nytimes.com